This micro-cap title hasn’t been driven upward via the AI rally nonetheless, but that doesn’t suggest it could possibly’t join the pack. Ideanomics (NASDAQ:IDEX) is recovering from a very hard 2022. at the moment focusing on ovarian most cancers, TumorGenesis final year marketed “its special ovarian cancer mobile lifestyle media … to a t